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ABSTRACT
Recent results from metaanalyses and observational stud-
ies have suggested that total abdominal hysterectomy
(TAH) is superior to laparoscopic supracervical hysterec-
tomy (LSH) for the treatment of benign gynecologic con-
ditions. However, because LSH is associated with fewer
intraoperative complications, shorter operative time, and
preserves patient anatomy and sexual function in compar-
ison with TAH, clinicians should reconsider the benefits of
LSH.
Key Words: Cervical dysplasia, Laparoscopic supracervi-
cal hysterectomy, Gynecologic surgery.
INTRODUCTION
Laparoscopic supracervical hysterectomy (LSH) has con-
tinued to represent a favorable alternative to total abdom-
inal hysterectomy (TAH) for the treatment of benign gy-
necologic conditions, particularly due to the reduced
complication rates, shorter surgery/hospital stay, and
prompt resumption of patient daily living activities.1–7
Nevertheless, studies continue to suggest that LSH should
not be used as a treatment for benign gynecological con-
ditions, particularly cervical dysplasia.8–14 The purpose of
this commentary is to address the primary objections
against LSH and further illustrate the benefits inherent in
this procedure.
Initially, the primary impetus for removal of the cervix at
the time of hysterectomy in patients with benign condi-
tions was to prevent cervical cancer.9 However, the inci-
dence of cancer in the cervical stump is extremely low and
primarily preventable due to latent disease progression,
pap smear technology, and HPV screening.8,15–18 There-
fore, removing this organ solely for the purpose of pre-
venting cervical cancer appears counterintuitive, espe-
cially considering that both at-risk patients and the general
nonhysterectomized population receive the same recom-
mended screening guidelines.9,19–21
Since LSH involves the removal of the uterine sec-
tion ostensibly related to the specific condition, the
operation fixes many gynecologic problems while it
conserves the patient’s anatomy and sexual function
by retaining the cervix and its mucous-secreting
glands.8,15,19,20,22 Furthermore, the cervix is not typically
associated with pelvic pain or bleeding, and thus pa-
tients can thereby avoid the common complaints of
vaginal dryness and dyspareunia.2
Studies have further indicated that removal of the normal
cervix can cause untoward bladder and bowel conse-
quences, including prolapse and urinary inconti-
nence.8,20,22,23 Additionally, prior research has reported
that LSH outcomes coincide with favorable rates of pro-
lapse and vaginal cuff dehiscence (VCD).22,23 In particular,
Hur et al22 examined the prevalence of VCD in a large
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SCIENTIFIC PAPERhysterectomy study, indicating that the condition has a
significantly following TAH compared with LSH.
Randomized controlled trials and metaanalyses have doc-
umented that LSH is associated with a higher incidence of
cervical stump complications (eg, cyclical bleeding and
urinary incontinence).12,13,24 However, the cyclical bleed-
ing with LSH is often slight and can be tolerated if the
patient receives adequate preoperative counseling.25 In
terms of stress urinary incontinence, TAH appears to be
associated with more favorable outcomes compared with
LSH, whereas there were no reported lower urinary tract
symptom (LUTS) differences between the 2 proce-
dures.12,13 We contend that because vaginal suspension
alters the bladder neck angle and reduces postoperative
incontinence, when performing LSH, consideration for
suspending both the vagina and the cervical stump may
significantly mitigate stress urinary incontinence.23,26,27
While there were no reported differences between TAH
and LSH regarding the incidence of LUTS, urinary tract
infections, incomplete bladder emptying and voiding
complications increased after TAH at 1-year follow-up but
decreased in the LSH patients.13 In an earlier surgical
study, Gimbel et al12 also reported a much higher inci-
dence of serious adverse events and perioperative blood
loss in patients treated with TAH compared with those
treated with LSH. Furthermore, the TAH group exhibited
more bladder/ureteral injuries, underwent longer opera-
tive times.
Patients who present with recurrent cervical dysplasia
should consider having their cervix removed if a total
hysterectomy is warranted. However, when a patient
initially presents with cervical dysplasia, LSH may be
preferable to hysterectomy particularly given the re-
portedly lower complication rates, reduced surgical
time, and earlier recovery.1–7 The combination of im-
proved prevention programs, patient adherence to annual
screening recommendations, and an informed community
appreciation of the virus’s vaccination distribution may
further render this issue inconsequential.17
We suspect that the controversy surrounding the removal
of the cervix is partially attributed to both insufficient LSH
outcome studies and because many gynecologic surgeons
are not formerly trained or experienced with this treat-
ment option.5 While we recognize that both the American
College of Obstetrics and Gynecology and a recent Co-
chrane analysis clearly state that TAH is more beneficial
than LSH in treating benign gynecologic conditions,24,28
clinicians should strongly consider the several encourag-
ing LSH findings and emerging studies that continue to
substantiate the efficacy of LSH for treating many common
benign gynecologic conditions.1,5,24,29
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